The aetiologic evaluation of adverse cutaneous reactions to penicillin
s is still not an easy problem to solve. Skin testing is usually carri
ed out intradermally with benzylpenicilloyl polylysine (BPO-PPL) and m
inor determinant mixture (MDM), but these are often unsuitable for the
detection of sensitivity to betalactam antibiotics. 101 selected subj
ects, with different cutaneous reactions to betalactams and with a cli
nical history of positive challenge, were skin tested (patch test, pri
ck test, intradermal test) with a standard betalactam series (amoxycil
lin, sodium penicillin G, ampicillin, bacampicillin, aztreonam, ceftri
azone, BPO-PPL, MDM). 1 or more positive reactions to skin tests, main
ly to intradermal tests, were observed in 47.5% of the subjects studie
d, especially in those with maculopapular eruptions, urticaria/angioed
ema and drug reactions caused by ampicillin and amoxycillin. Cross-sen
sitivity was demonstrated in 22.8% of cases and was due almost solely
to the semisynthetic penicillins. Finally, to increase the yield in de
tecting positive patients, it is necessary that ampicillin and amoxyci
llin be tested in addition to major and minor determinants. (C) Munksg
aard, 1997.